Uric acid and the bone and muscle status in patients with rheumatoid arthritis
https://doi.org/10.47360/1995-4484-2025-374-379
Abstract
The aim – to evaluate the relationship between bone mineral density (BMD) and muscle mass with uric acid (UA) level in women with rheumatoid arthritis (RA).
Materials and methods. A total of 182 women with confirmed RA (median age 61 [53; 66] years) were examined. Clinical and laboratory examination was performed, including blood serum UA testing, dual-energy X-ray absorptiometry in standard measurement areas and the whole body.
Results. The UA level in the examined group was 258.5 [198.0; 309.5] μmol/l. A comparative analysis depending on the UA level quartile revealed significant differences between the groups in age, body mass index, appendicular muscle index (AMI), total muscle mass (TMM), and total muscle index (TMI). The direct stepwise regression method showed that the UA level in women with RA was not associated with the BMD value in all measurement areas (p>0.05), but was associated with all quantitative indices of muscle mass (with AMI – β=0.29; with TMM – β=0.37; with TMI – β=0.35; p<0.001).
Conclusion. In women with RA, no independent association was found between UA level and BMD in standard measurement areas. A significant positive association between UA and appendicular and total muscle mass was revealed.
About the Authors
O. V. Dobrovolskaya
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Olga V. Dobrovolskaya
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
none
N. V. Demin
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Nikolay V. Demin
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
none
M. V. Kozyreva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Maria V. Kozyreva
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
none
N. V. Toroptsova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Natalia V. Toroptsova
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
none
References
1. Belov BS, Bukhanova DV, Tarasova GM, Muravyeva NV. The problem of lower respiratory tract infections in rheumatology: Relevance and ways of solution. Effective Pharmacotherapy. 2020;16(6):58-66 (In Russ.). doi: 10.33978/2307-3586-2020-16-6-58-66
2. Bukhanova DV, Belov BS, Tarasova GM, Soloviev SK, Ananyeva LP, Popkova TV, et al. Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova). Medical Council. 2019;(9):86-91 (In Russ.). doi: 10.21518/2079-701X-2019-9-86-91
3. Baranova MM, Muravyeva NV, Belov BS, Korotaeva TV, Glukhova SI. Comorbid infections in patients with spondyloarthritis: Frequency, structure and risk factors. Modern Rheumatology Journal. 2023;17(4):64-70 (In Russ.). doi: 10.14412/1996-7012-2023-4-64-70
4. Avdeev SN, Alyeva MN, Baranov AA, Bikmieva AV, Briko NI, et al. Federal clinical guidelines on vaccination of pneumococcal infection in children and adults. Russian Journal оf Preventive Medicine. 2023;26(9-2):3-23 (In Russ.). doi: 10.17116/profmed2023260923
5. Wakabayashi A, Ishiguro T, Takaku Y, Miyahara Y, Kagiyama N, Takayanagi N. Clinical characteristics and prognostic factors of pneumonia in patients with and without rheumatoid arthritis. PLoS One. 2018;13(8):e0201799. doi: 10.1371/journal.pone.0201799
6. Rondaan C, Furer V, Heijstek MW, Agmon-Levin N, Bijl M, Breedveldet FC, et al. Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: A systematic literature review for the 2019 update of EULAR recommendations. RMD Open. 2019;5:e001035. doi: 10.1136/rmdopen-2019-001035
7. Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79(1):39-52. doi: 10.1136/annrheumdis-2019-215882
8. Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, et al. 2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2023;75(3):333-348. doi: 10.1002/art.42386
9. Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, AgmonLevin N, et al. Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): A systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD Open. 2019;5(2):e001041. doi: 10.1136/rmdopen-2019-001041
10. Coulson E, Saravanan V, Hamilton J, Heycock C, Rynne M, Kelly C. Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate. Ann Rheum Dis. 2011;70:1289-1291.
11. Izumi Y, Akazawa M, Akeda Y, Tohma S, Hirano F, Ideguchi H, et al. The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: A double-blinded, randomized, placebo-controlled trial. Arthritis Res Ther. 2017;19(1):15. doi: 10.1186/s13075-016-1207-7
12. Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, et al. Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinicaltrial. Arthritis Rheum. 2010;62(1):64-74. doi: 10.1002/art.25034
13. Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, et al. Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients. Arthritis Res Ther. 2015;17:357. doi: 10.1186/s13075-015-0863-3
14. Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta. 2018;484:150-163. doi: 10.1016/j.cca.2018.05.046
15. Shen X, Zhang M, Cai H, Leslie WD, Lix LM, Jiang D, et al. Associ ations of global biomarkers of oxidative stress with osteoporosis, bone microstructure and bone turnover: Evidence from human and animal studies. Bone. 2024;183:117077. doi: 10.1016/j.bone.2024.117077
16. Lee HN, Kim A, Kim Y, Kim GT, Sohn DH, Lee SG. Higher serum uric acid levels are associated with reduced risk of hip osteoporosis in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore). 2020;99(24):e20633. doi: 10.1097/MD.0000000000020633
17. Kim S, Lee S, Kwon H. Association between serum uric acid level and bone mineral density in men more than 50 years of age. Front Endocrinol (Lausanne). 2023;14:1259077. doi: 10.3389/fendo.2023.1259077
18. Liu X, Chen X, Hu F, Xia X, Hou L, Zhang G, et al. Higher uricacid serum levels are associated with sarcopenia in west China: A cross-sectional study. BMC Geriatr. 2022;22(1):121. doi: 10.1186/s12877-022-02817-x
19. Miller SG, Matias C, Hafen PS, Law AS, Witczak CA, Brault JJ. Uric acid formation is driven by crosstalk between skeletal muscle and other cell types. JCI Insight. 2024;9(2):e171815. doi: 10.1172/jci.insight.171815
20. Chen L, Wu L, Li Q, Hu Y, Ma H, Lin H, et al. Hyperuricemia associated with low skeletal muscle in the middle-aged and elderly population in China. Exp Clin Endocrinol Diabetes. 2022;130(8):546-553. doi: 10.1055/a-1785-3729
Review
For citations:
Dobrovolskaya O.V., Demin N.V., Kozyreva M.V., Toroptsova N.V. Uric acid and the bone and muscle status in patients with rheumatoid arthritis. Rheumatology Science and Practice. 2025;63(4):374-379. (In Russ.) https://doi.org/10.47360/1995-4484-2025-374-379
Views:
29
Email this article 